Pharma · GMP

WHO-GMP Consultant for Pharmaceutical Manufacturing

Align pharmaceutical quality systems with WHO TRS GMP expectations, update SMF and SOP records, and prepare COPP (CPP) application documentation. NQSC supports gap analysis, validation evidence, mock audit readiness, and CDSCO coordination. NQSC does not issue certificates or conduct authority inspections.

Review Required DocumentsReview Required Documents
  • 25+Years Experience
  • 500+Companies
  • WHO-GMP Support
  • Pharma · COPP

WHO-GMP and COPP readiness

  • 1Confirm applicable WHO TRS GMP annex
  • 2Complete gap analysis and SMF update
  • 3Close validation and self-inspection findings
  • 4Prepare COPP dossier and inspection records
TRS 986COPPSMFSchedule MCDSCO

Which GMP pathway applies?

  • Schedule M upgrade (India)PQS · QRM · validation · data integrity
  • First COPP / export GMPTRS 986 · SMF · CDSCO joint inspection
  • COPP revalidation or added productProduct list · labeling · inspection update
  • API manufacturing siteTRS 957 Annex 2 · API validation
  • Sterile finished dosageTRS 1044 Annex 2 · aseptic controls

Who needs this

Who needs WHO-GMP and COPP support

NQSC supports API and finished dosage manufacturers, export units, Schedule M upgrade sites, CMOs, and teams preparing for authority GMP inspection.

  • API manufacturers

    Active pharmaceutical ingredient sites aligning systems with WHO TRS 957 Annex 2 and export customer expectations.

    • TRS 957
    • API
    • Validation
  • Finished dosage manufacturers

    Formulation sites preparing WHO TRS 986 Annex 2 records, batch documentation, and product quality review.

    • TRS 986
    • Batch records
    • PQR
  • Export units seeking COPP

    Sites filing for Certificate of Pharmaceutical Product (CPP/COPP) under the WHO Certification Scheme through CDSCO.

    • COPP
    • CPP
    • CDSCO
  • Schedule M upgrade sites

    Indian licensed sites strengthening pharmaceutical quality systems, validation, and data integrity under Schedule M.

    • Schedule M
    • PQS
    • QRM
  • Pre-inspection and mock audit teams

    QA teams preparing self-inspection programmes, CAPA closure, and mock audits before authority GMP inspection.

    • Self-inspection
    • CAPA
    • Mock audit
  • Contract and loan manufacturing sites

    CMOs and loan-license units aligning SMF, batch records, and principal MAH documentation requirements.

    • CMO
    • Contract mfg
    • SMF

Compare pathways

Schedule M compliance vs COPP export readiness

Domestic licensed manufacturing and export COPP filing follow different evidence sets. WHO Prequalification is a separate dossier and inspection path for listed procurement products.

Schedule M / domestic GMP

Best for: licensed Indian manufacturing sites subject to state or CDSCO GMP inspections.

  • Pharmaceutical quality system, validation, and data integrity under Schedule M
  • Self-inspection, batch documentation, and deviation or CAPA records
  • Baseline for legal operation of a drug manufacturing license in India

Relevant forms

  • Schedule M
  • PQS
  • Validation
  • Self-inspection

COPP / WHO-type export evidence

Best for: export markets that rely on the WHO Certification Scheme and CDSCO-issued COPP.

  • Alignment with WHO TRS GMP annexes (986, 957, 1044 as applicable)
  • SMF, inspection readiness, and CPP dossier fields per national guidance
  • CDSCO document scrutiny and joint inspection for grant or revalidation

Relevant forms

  • COPP
  • TRS 986
  • SMF
  • CDSCO

Documentation

Documentation typically reviewed for WHO-GMP and COPP readiness

Grouped for gap review before COPP filing or authority GMP inspection.

  • Quality System

    • Quality manual and pharmaceutical quality system
    • Change control, deviation, and CAPA procedures
    • Self-inspection and quality audit programme
    • Management review and training records
  • Site Master File & Validation

    • Site master file (SMF)
    • Validation master plan
    • IQ/OQ/PQ protocols and summary reports
    • HVAC, water, and utility qualification records
  • Production & Records

    • Batch manufacturing and packaging records
    • Line clearance and reconciliation records
    • In-process and finished product controls
    • Stability and retention sample records
  • Materials & Suppliers

    • Vendor qualification and approval records
    • Certificate of analysis and material release
    • Storage, dispensing, and label control
    • Returned goods and recall procedures
  • COPP & Regulatory Submission

    • Manufacturing license copies and product lists
    • Summary of product characteristics or approved labeling
    • COPP (CPP) application forms and annexes
    • CDSCO COPP application and inspection correspondence

Note: Final document scope is confirmed after reviewing site layout, product list, manufacturing license scope, and target COPP or inspection pathway.

Process

From TRS gap analysis to COPP filing support

A structured process for annex scoping, gap analysis, documentation updates, mock audit readiness, and COPP application support.

  1. Product type and TRS annex scope

    Confirm API vs finished dosage, sterile vs non-sterile scope, and applicable WHO TRS GMP annex before documentation work.

  2. Gap analysis

    Review site systems against WHO GMP expectations and Schedule M requirements where the site holds an Indian manufacturing license.

  3. SMF, SOP, and batch documentation

    Update site master file, core procedures, batch manufacturing records, and quality system evidence.

  4. Validation and training closure

    Close validation, qualification, training, and self-inspection findings with objective evidence.

  5. Mock audit readiness

    Run pre-inspection reviews, document trails, and CAPA closure checks before authority inspection.

  6. COPP filing and query support

    Support COPP application documentation and responses to CDSCO or state authority queries after submission.

How NQSC helps

Support across GMP documentation, validation, and COPP readiness

NQSC supports TRS mapping, SMF and SOP updates, validation evidence, self-inspection programmes, COPP dossier structuring, and pre-inspection coordination.

  • TRS annex mapping and gap analysis

    Map site activity to WHO TRS GMP texts (TRS 986, TRS 957, TRS 1044, TRS 1060) and Schedule M where the site is India-licensed.

  • SMF and SOP documentation

    Structure site master file, quality manual, SOPs, batch records, and forms aligned to site scope and product type.

  • Validation and qualification support

    Support validation master plans, IQ/OQ/PQ protocols, utility qualification, and equipment qualification records.

  • Self-inspection and CAPA programmes

    Help plan self-inspections, deviation handling, CAPA workflows, and management review evidence.

  • COPP application dossier support

    Structure COPP (CPP) application records, product lists, labeling references, and CDSCO submission checklists.

  • Pre-inspection and query response

    Support mock audits, document retrieval readiness, and responses to authority queries after filing.

Avoid delays

Avoidable issues that delay COPP and GMP inspection readiness

Issues NQSC often sees during WHO GMP gap reviews and COPP application preparation.

  • Schedule M treated as COPP-ready

    Domestic Schedule M compliance alone does not replace a COPP dossier review, SMF alignment, and export inspection readiness.

  • SMF not matching the site

    Site master file layout, flows, or equipment lists not aligned with actual manufacturing areas and operations.

  • Validation gaps

    Validation master plan missing, incomplete, or not linked to critical systems, utilities, and processes.

  • Batch traceability gaps

    Weak linkage between raw materials, intermediates, finished batches, and distribution records.

  • CAPA without effectiveness checks

    Corrective actions closed without verifying recurrence prevention or systemic root cause closure.

  • ISO mistaken for WHO GMP

    ISO 9001 or other ISO certificates treated as proof of WHO GMP compliance without authority GMP verification.

Client trust

Client feedback on NQSC GMP and compliance support

Feedback from teams supported across GMP documentation, audit readiness, quality system upgrades, and regulatory coordination.

  • ISO · CE · CDSCO

    Excellent support throughout certification activities, including ISO, CE marking and CDSCO submissions.

    Neeraj Mishra

    Tarun Enterprises

  • CDSCO · Manufacturing

    Fast and accurate service.

    Rakesh Marwah

    Aditya Dispomed Products Pvt Ltd

  • Regulatory Support

    We are fully satisfied with the services provided by NQSC.

    Rakesh Singh

    MDD Medical Systems (India) Pvt Ltd

Selected clients supported by NQSC

FAQ

Questions before you apply

Short answers on WHO TRS GMP texts, COPP, Schedule M, inspections, and how NQSC supports your pathway.

WHO publishes GMP in the Technical Report Series (TRS). TRS 986 Annex 2 covers main principles for pharmaceutical products. Additional annexes address APIs (TRS 957), sterile products (TRS 1044), excipients (TRS 1060), and quality risk management (TRS 981). NQSC supports documentation aligned to the annex that matches your site scope.

The Certificate of Pharmaceutical Product (often called COPP or CPP) is the primary document in the WHO Certification Scheme on the quality of pharmaceutical products moving in international commerce. Importing authorities use it to assess marketing status and manufacturer GMP compliance in the exporting country.

CDSCO guidance describes document scrutiny and joint inspection for grant or revalidation of COPPs. Inspections are conducted by national regulatory authorities, not by NQSC. WHO Prequalification runs separate GMP inspections for sites linked to prequalification dossiers.

Schedule M under the Drugs and Cosmetics Rules is the mandatory GMP framework for licensed manufacturing in India. COPP and WHO-type export evidence follow the WHO Certification Scheme and TRS GMP texts. Revised Schedule M is closer to WHO expectations, but export filing still needs a separate COPP readiness review.

WHO Prequalification assesses specific products for UN and partner procurement, including dossier review and GMP inspection of submitted API or finished product sites. COPP is issued by the national authority under the Certification Scheme. The two pathways serve different purposes and are not interchangeable.

No. NQSC provides documentation, gap analysis, and inspection readiness support. Certificates and inspection outcomes depend on site performance and findings from the competent authority or WHO Prequalification where applicable.

Planning COPP or WHO-GMP inspection readiness?

Share dosage forms, API vs finished product scope, sterile or non-sterile operations, target markets, and inspection timeline. NQSC will outline GMP gap analysis and documentation priorities.

Documentation support only. Certificates and inspections are conducted by competent authorities.